Search

everythinglearnresearchcommunity

for

Search:↓

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Heat treatment increases hair loss in certain mice.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

The conclusion of the case is not provided in the summary.

The microbiome may be linked to hair loss and could be a target for new treatments.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

Spironolactone may help reduce hair loss in androgenic alopecia.

Spironolactone may help reduce hair loss in androgenic alopecia.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

A 65-year-old man with sudden abdominal pain and seizures was diagnosed with a rare, non-traumatic splenic rupture and treated without surgery.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Blood tests confirmed a baby in the womb had a CMV infection.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

An 11-year-old girl with compulsive hair pulling was successfully treated with therapy and medication.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.